Neo Ivy Capital Management’s Globus Medical GMED Stock Holding History

Neo Ivy Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.74M	Buy	+20,206	New	+$1.81M	0.46%	86
2025 Q4	–	Sell	-10,252	Closed	-$587K	–	421
2025 Q3	$587K	Buy	10,252 +4,937	+93%	+$284K	0.14%	221
2025 Q2	$314K	Sell	5,315 -845	-14%	-$54.6K	0.1%	246
2025 Q1	$451K	Buy	+6,160	New	+$509K	0.14%	201
2022 Q3	–	Sell	-2,161	Closed	-$121K	–	445
2022 Q2	$121K	Buy	+2,161	New	+$142K	0.32%	105
2021 Q4	–	Sell	-2,960	Closed	-$141K	–	505
2021 Q3	$141K	Buy	+2,960	New	+$238K	0.16%	193
2020 Q4	–	Sell	-4,286	Closed	-$212K	–	481
2020 Q3	$212K	Buy	4,286 +1,326	+45%	+$68.4K	0.21%	187
2020 Q2	$141K	Buy	+2,960	New	+$143K	0.16%	193

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neo Ivy Capital Management's GMED Position: Q1 2026 in Review

Neo Ivy Capital Management opened a new position in Globus Medical (GMED) in Q1 2026: 20,206 shares worth $1.74M. The stake represents 0.46% of the portfolio and ranks #86 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in GMED as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in GMED in Q2 2020 and has held it in 8 quarters since. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Neo Ivy Capital Management held 20,206 shares of Globus Medical worth $1.74M as of Q1 2026.
Globus Medical was a new Neo Ivy Capital Management position in Q1 2026.
Globus Medical made up 0.46% of Neo Ivy Capital Management's portfolio in Q1 2026, its #86 holding.
Neo Ivy Capital Management first reported a position in Globus Medical in Q2 2020 and has held it in 8 quarters since.
605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.